- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sanfilippo Syndrome Type A in Canada
Total 245 results
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Blood ServicesTerminatedLeukemia | Myelodysplastic SyndromeCanada
-
Ottawa Hospital Research InstituteSuspendedAcute Leukemia | Myelodysplastic SyndromeCanada
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaCanada, United States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesCanada, United States
-
University of British ColumbiaUltragenyx Pharmaceutical IncUnknownGlucose Transporter Type 1 Deficiency SyndromeCanada
-
Nova Scotia Health AuthorityUnknown
-
NCIC Clinical Trials GroupBayerCompletedMyelodysplastic Syndromes | LeukemiaCanada
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
Liminal BioSciences Ltd.CompletedMetabolic Syndrome | Type 2 DiabetesCanada
-
University of Las Palmas de Gran CanariaRecruitingType I Complex Regional Pain SyndromeSpain
-
Hoffmann-La RocheTerminatedMyelodysplastic Syndromes, Myelogenous Leukemia, AcuteUnited States, Canada, Germany
-
Unity Health TorontoCompletedMetabolic Syndrome | Type 2 DiabetesCanada
-
Institut de Recherches Cliniques de MontrealCompletedMetabolic Syndrome | Type 1 DiabetesCanada
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
BioMarin PharmaceuticalTerminatedMorquio A Syndrome | MPS IV A | Mucopolysaccharidosis IVAFrance, United Kingdom, Taiwan, United States, Argentina, Netherlands, Canada, Brazil, Germany, Italy
-
University of ManitobaDSM Nutritional Products, Inc.CompletedNAFLD | TYPE 2 DIABETES | METABOLIC SYNDROMECanada
-
Nova Scotia Health AuthorityTerry Fox Research InstituteCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)Canada
-
The Hospital for Sick ChildrenCompletedX-linked Lymphoproliferative Syndrome Type 2 (XLP-2)Canada
-
University of AlbertaNovartisCompletedRefractory Ascites | Type 2 Hepatorenal SyndromeCanada
-
University Health Network, TorontoCompletedBasal Cell Nevus SyndromeCanada
-
University of CalgaryCompletedMetabolic Syndrome | Type 2 Diabetes | Impaired Glucose ToleranceCanada
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedFamilial Chylomicronemia Syndrome | Lipoprotein Lipase Deficiency | Hyperlipoproteinemia Type 1Canada
-
University of TorontoAgriculture and Agri-Food CanadaCompletedObesity | Metabolic Syndrome | Type II Diabetes MellitusCanada
-
Novartis PharmaceuticalsCompletedNevoid Basal Cell Carcinoma Syndrome | Basal Cell Carcinoma | Gorlin SyndromeBelgium, Austria, Germany, Canada
-
Vancouver General HospitalNovo Nordisk A/STerminated
-
University of TorontoAgriculture and Agri-Food Canada; Pulse CanadaCompletedObesity | Metabolic Syndrome | Type II Diabetes MellitusCanada
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
GlaxoSmithKlineTerminated
-
University of GuelphPublic Health Agency of Canada (PHAC)CompletedObesity | Metabolic Syndrome | Dyslipidemia | Type-2 DiabetesCanada
-
Astex Pharmaceuticals, Inc.CompletedAML | MDS | CMMLUnited States, Canada
-
CelgeneActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteFrance, United States, Canada, Norway, Spain, United Kingdom
-
University Health Network, TorontoCompletedObesity | Hepatitis C | Metabolic Syndrome | Insulin ResistanceCanada
-
Liminal BioSciences Ltd.TerminatedType 2 Diabetes Mellitus | Metabolic SyndromeCanada
-
University of TorontoUnknownCardiovascular Diseases | Mortality | Metabolic Syndrome | Type 2 Diabetes | AdiposityCanada
-
Aeglea BiotherapeuticsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedMyelodysplastic Syndromes | Myelogenous Leukemia, AcuteUnited States, Canada
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
BioMarin PharmaceuticalICON plcCompletedMucopolysaccharidosis IV Type A | Morquio A Syndrome | MPS IVAUnited States, United Kingdom, Australia, Taiwan, Belgium, Malaysia, Austria, Canada, Portugal, France, Ireland, Czechia, Denmark, Italy, Netherlands, Poland, Puerto Rico
-
University of CalgaryCompletedDependency on Medications Prescribed for Patient | Types of Seizures and Epileptic SyndromesCanada
-
MedicureCompletedHypertension | Metabolic Syndrome | Diabetes Mellitus Type 2Canada
-
Bellus Health IncCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome XCanada
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IV AUnited States, Canada, France, Taiwan, Argentina, Colombia, Spain, Turkey, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, United Kingdom, Germany, Norway, Portugal, Italy, Qatar
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Australia, Canada
-
University of AlbertaWithdrawnHemorrhagic Stroke | Reversible Cerebral Vasoconstriction Syndrome | Cerebral Venous Sinus Thrombosis | Headache, Migraine | Stroke (CVA) or TIA | Botulinum Toxins, Type A | Carotid Dissection Artery | Vertebral Dissection ArteryCanada
-
University of GuelphCompletedHypertension | Obesity | Type 2 Diabetes Mellitus | HyperlipidemiaCanada
-
BioMarin PharmaceuticalCompletedMPS IV AUnited States, Canada, France, United Kingdom, Taiwan, Argentina, Colombia, Japan, Saudi Arabia, Netherlands, Denmark, Korea, Republic of, Brazil, Germany, Portugal, Italy, Qatar